Buprenorphine 62756-0459
Product NDC
62756-0459- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- February 17, 2016
- Listing Expires
- December 31, 2027
- Application
- ANDA201760
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(2)
3 BLISTER PACK in 1 CARTON (62756-459-64) / 10 TABLET in 1 BLISTER PACK
30 TABLET in 1 BOTTLE (62756-459-83)